ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 18335 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 18335; 2) Community: the network communities that were significantly associated with the response to NSC 18335; 3) Molecule: the relationships between components within communities and NSC 18335; 4) MDR: the compounds that were significantly associated with the NSC 18335.

NSC Compound Enrichment Correlation
NSC 758119 (1R,6S,11aS,13S,14aR)-1,13-dihydroxy-6-vinyl-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-4-one 0.0282295482823984 -0.2230938
NSC 138425 Kinamycin C 0.0282295482823988 0.20804435
NSC 139105 Soluble Baker's Antifol 0.0282295482823988 0.20685993
NSC 372474 Null 0.0354402685381448 0.23261838
NSC 622700 Methanaminium, (2-oxo-1,3-cyclohexanediyl)bis(methyl)bis [N,N,N-trimethyl-, diiodide 0.0354402685381448 0.19562844
NSC 638265 Null 0.0354402685381448 0.27801655
NSC 639517 Cyclopentanone, 2-[(4-chlorophenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.0354402685381448 0.037572768
NSC 668257 2,4(1H,3H)-Pyrimidinedione, 1-[[2-(4-chlorophenyl)- tetrahydro-4-methylene-5-oxo-2-furanyl]methyl]-5-methyl- 0.0354402685381448 0.097464133
NSC 116640 Null 0.0355196177493895 -0.0045579679
NSC 116789 Acovenoside B 0.0355196177493895 0.17467204
Total:84  Current:57    [First] [Prev] [Next] [Last]